Diffuse blastoid B-cell lymphoma: A histologically aggressive variant of t(14;18)-negative follicular lymphoma

Modern Pathology

Volumn 22, Issue 11, 2009, Pages 1507-1517

  Chiu, April ^a   Frizzera, Glauco ^a   Mathew, Susan ^a   Hyjek, Elizabeth M ^a   Chadburn, Amy ^a   Tam, Wayne ^a   Knowles, Daniel M ^a   Orazi, Attilio ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

B cell lymphoma; CD43; Chromosome 18; Diffuse blastoid; Follicular lymphoma

Indexed keywords

CD5 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERFERON REGULATORY FACTOR 4; LEUKOSIALIN; MYC PROTEIN; PREDNISONE; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME 18; CHROMOSOME DELETION 13; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOMA; MALE; MANTLE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL;

EID: 70350692283     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.106     Document Type: Article

References (48)

1. Swerdlow SH, Campo E, Harris NL et al (eds). WHO Classification Of Tumors Of The Haematopoietic And Lymphoid Tissues. IARC: Lyon, 2008
2. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ. et al. (eds) PCR Protocols: A Guide To Methods And Applications 1990, Academic Press: San Diego
3. Diss TC, Peng H, Wotherspoon AC, et al. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993;169: 291-295
4. McCarthy KP, Sloane JP, Kabarowski JH, et al. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol 1992;1:173-179
5. Nanjangud G, Rao PH, Teruya-Feldstein J, et al. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression. Cytogenet Genome Res 2007;118:337-344
6. Dierlamm J, Murga Penas EM, Bentink S, et al. Molecular mechanisms in malignant lymphomas'. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica 2008;93:688-696
7. Katzenberger T, Kalla J, Leich E, et al. A distinctive subtype of t(14;18) negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 2009;113:1053-1061
8. Fu K, Weisenburger DD, Greiner TC, et al. Lymphoma/ leukemia molecular profiling project. Cyclin D1-nega-tive mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106: 4315-4321
9. Attygalle A, Al Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002;99:627-633
10. de Leval L, Savilo E, Longtine J, et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/ bcl-6+ phenotype. Am J Surg Pathol 2001;25:395-400
11. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511
12. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282
13. Naresh KN. MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. Hae-matologica 2007;92:267-268
14. Keller CE, Nandula S, Fisher J, et al. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. Am J Clin Pathol 2008;130: 193-201
15. Karube K, Guo Y, Suzumiya J, et al. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 2007;109:3076-3079
16. Horsman DE, Okamoto I, Ludkovski O, et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol 2003;120: 424-433
17. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002;99:3806-3812
18. Katzenberger T, Ott G, Klein T, et al. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol 2004;165:481-490
19. Bosga-Bouwer AG, van den Berg A, Haralambieva E, et al. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? Hum Pathol 2006;37:528-533
20. Kaleem Z, White G, Zutter MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lym-phomas. Am J Clin Pathol 2001;115:396-403
21. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol 1995;147:207-216
22. Harada S, Suzuki R, Uehira K, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia 1999;13:1441-1447
23. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol 1999;105:1133-1139
24. Lai R, Weiss LM, Chang KL, et al. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol 1999;111: 488-494
25. Kingma DW, Imus P, Xie XY, et al. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms. Cytometry 2002; 50:243-248
26. Inaba T, Shimazaki C, Sumikuma T, et al. Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma. Br J Haematol 2000;109:592-599
27. Ferry JA, Yang WI, Zukerberg LR, et al. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 1996;105:31-37
28. Wenzel C, Dieckmann K, Fiebiger W, et al. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour. Leuk Lymphoma 2001;42:823-829
29. Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol 2003;119:218-230
30. Ballesteros E, Osborne BM, Matsushima AY. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol 1998;22: 201-207
31. Horsman DE, Connors JM, Pantzar T, et al. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001;30:375-382
32. Knutsen T. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surv 1997;30:163-192
33. Armitage JO, Sanger WG, Weisenburger DD, et al. Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21). J Natl Cancer Inst 1988;80:576-580
34. Mohamed AN, Palutke M, Eisenberg L, et al. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet Cytogenet 2001;126:45-51
35. Boonstra R, Bosga-Bouwer A, Mastik M, et al. Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. Hum Pathol 2003; 34:915-923
36. Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002;16:2366-2378
37. Dohner H, Stilgenbauer S, Dohner K, et al. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytoge-netic analysis. J Mol Med 1999;77:266-281
38. Shaughnessy Jr J, Tian E, Sawyer J, et al. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood 2000;96:1505-1511
39. Maestro R, Piccinin S, Doglioni C, et al. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 1996;56: 1146-1150
40. Chen C, Frierson Jr HF, Haggerty PF, et al. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas. Genomics 2001;77:135-144
41. Dohner H, Stilgenbauer S, Fischer K, et al. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 1997; 11(Suppl 2):S19-S24
42. Shaughnessy Jr J, Tian E, Sawyer J, et al. Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. Br J Haematol 2003;120:44-52
43. Hoglund M, Sehn L, Connors JM, et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004;39:195-204.
44. Kramer MHH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large b-cell lymphoma. Blood 1998;92: 3152-3162
45. Karsan A, Gascoyne RD, Coupland RW, et al. Combination of t(14;18) and a Burkitt0s type translocation in B-cell malignancies. Leuk Lymphoma 1993;10: 433-441
46. Ye BH, Rao PH, Chaganti RS, et al. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993;53: 2732-2735
47. Kerckaert JP, Deweindt C, Tilly H, et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lympho-mas. Nat Genet 1993;5:66-70
48. Natkunam Y, Warnke RA, Zehnder JL, et al. Blastic/ blastoid transformation of follicular lymphoma: im-munohistologic and molecular analyses of five cases. Am J Surg Pathol 2000;24:525-534